Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
eltrombopag (promacta) (1 trial)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Lymphoproliferative Disorders (Phase 2)
Purpura (Phase 2)
Purpura, Thrombocytopenic (Phase 2)
Purpura, Thrombocytopenic, Idiopathic (Phase 2)
Thrombocytopenia (Phase 2)
Trials (1 total)
Trial APIs (1 total)